The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Putilina M.V.

Pirogov Russian National Research Medical University

Current concepts about small vessel disease

Authors:

Putilina M.V.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(11): 65‑73

DOI: 10.17116/jnevro201911911165

Read: 4481 times

Download PDF (RU)
Contact the author
Table of contents

CURRENT CONCEPTS ABOUT SMALL VESSEL DISEASE
CURRENT CONCEPTS ABOUT SMALL VESSEL DISEASE

To cite this article:

Putilina MV. Current concepts about small vessel disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(11):65‑73. (In Russ.)
https://doi.org/10.17116/jnevro201911911165

Подписка 2025-2 (S.S. Korsakov Journal of Neurology and Psychiatry)
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Mediasphera_Net
Close metadata
Recommended articles:
Features of cognitive impairment in bipo­lar affe­ctive diso­rder. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(6):15-19
Cognitive impairments and emotional diso­rders and their correction in peri­menopausal women. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(6):48-53
Inte­grative asse­ssment of the effe­ctiveness and safety of outpatient use of Pica­milon. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(7):119-130
Indi­cators of cognitive impairment of varying seve­rity in the acute period of ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(8-2):14-20
Possibilities of mirror therapy in cognitive reha­bilitation after stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(8-2):64-71
Clinical effi­cacy and safety of Pica­milon in patients with progressive chro­nic cere­bral ischemia. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(8):71-80
Reco­gnan (citicoline) prescribing in cere­brovascular diseases and type 2 diabetes mellitus patients. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(9):23-27
Asso­ciation between previous appe­ndectomy and cognitive impairment in adults: a case-control study. Piro­gov Russian Journal of Surgery. 2024;(7):73-77
A personalized gene­tic approach to surgical treatment of caro­tid artery tortuosity. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;(4):436-444
Clinical and meta­bolic features of neurocognitive testing in children and adolescents with type 1 diabetes mellitus. Russian Journal of Preventive Medi­cine. 2024;(8):60-65

Small vessel disease is a very common pathological process, which plays a key role in the development of stroke and cognitive impairment and, at the same time, affects other organs. The search for optimal drugs for prevention and treatment of small vessel disease has been continuing. The results of new studies enable further development of new treatment strategies. Currently, the drugs with neurotrophic properties become more and more important.

Keywords:

small vessel disease
cognitive impairment
hereditary diseases

Authors:

Putilina M.V.

Pirogov Russian National Research Medical University

Received:

05.06.2019

Accepted:

11.10.2019

List of references:

  1. Pantoni L, Gorelick PhB. A book review on Cerebral Small Vessel. Disease: Cambridge University Press, Cambridge, UK; 2014. https://doi.org/10.1017/CBO9781139382694
  2. Charidimou A. Book review: Cerebral small vessel disease. What’s the big deal about small vessels? Front Neurol. 6:175. Received: 14 July 2015; Accepted: 27 July 2015; Published: 10 August 2015. https://doi.org/10.3389/fneur.2015.00175
  3. Tsai CF, Thomas B, Sudlow CL. Epidemiology of stroke and its subtypes in Chinese vs white populations: a systematic review. Neurology. 2013;81:264-272.  https://doi.org/10.1212/WNL.0b013e31829bfde3
  4. Kwon HM, Lynn MJ, Turan TN. Frequency, risk factors, and outcome of coexistent small vessel disease and intracranial arterial stenosis: results from the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) Trial. JAMA Neurol. 2016;73:36-42.  https://doi.org/10.1001/jamaneurol.2015.3145
  5. Harold P, Adams Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE III. Classification of Subtype of Acute Ischemic Stroke. Definitions for Use in a Multicenter Clinical Trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24:1:35-41.  https://doi.org/10.1161/01.STR.24.1.35
  6. Wardlaw JM, Smith EE, Biessels GJ. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12:822-838.  https://doi.org/10.1016/S1474-4422(13)70124-8
  7. Issac TGr, Chandra SR, Christopher R, Rajeswaran J, Philip V. Cerebral Small Vessel Disease Clinical, Neuropsychological, and Radiological Phenotypes, Histopathological Correlates, and Described Genotypes. A Review Journal of Geriatrics Volume. 2015;Article ID 564870:11.  https://doi.org/10.1155/2015/564870
  8. Moran C, Phan TG, Srikanth VK. Cerebral small vessel disease: a review of clinical, radiological, and histopathofogical phenotypes. Int J Stroke. 2012;7:1:36-46. Epub 2011 Nov 24.  https://doi.org/10.1111/j.1747-4949.2011.00725.x
  9. Tojima M, Saito S, Yamamoto Y, Mizuno T, Ihara M, Fukuda H. Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy with a Novel NOTCH3 Cys323Trp Mutation Presenting Border-Zone Infarcts: A Case Report and Literature Review. J Stroke Cerebrovasc Dis. 2016;25(8):128-130. Epub 2016. https://doi.org/10.1016/j.jstrokecerebrovasdis.2016.05.013
  10. Meester JAN. Overlapping but distinct roles for NOTCH receptors in human cardiovascular disease. Clin Genet. 2018. https://doi.org/10.1111/cge.13382
  11. Di Donato I. Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) as a model of small vessel disease: update on clinical, diagnostic, and management aspects. BMC Med. 2017;15(1):41.  https://doi.org/10.1186/s12916-017-0778-8
  12. Maeda S, Nakayama H, Isaka K. Familial unusual encephalopathy of Binswanger’s type without hypertension. Folia Psychiatr Neurol Jpn. 1976;30:165-177. 
  13. Uemura M, Nozaki H, Onodera O. Cerebral Autosomal Recessive Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CARASIL). Brain Nerve. 2017;69(1):25-33.  https://doi.org/10.11477/mf.1416200631
  14. Lanfranconi S, Markus HS. COL4A1 mutations as a monogenic cause of cerebral small vessel disease: a systematic review. Stroke. 2010;41(8):513-518.  https://doi.org/10.1161/STROKEAHA.110.581918
  15. Alamowitch S, Plaisier E, Favrole P. Cerebrovascular disease related to COL4A1 mutations in HANAC syndrome. Neurology. 2009;73(22):1873-1882. ID: NBK7046. PMID: 20301768.
  16. Winkler D. Hereditary systemic angiopathy (HSA) with cerebral calcifications, retinopthy, progressive nephropathy, and hepatopathy. J Neurol. 2008;255:77-78.  https://doi.org/10.1007/s10072-014-1944-9
  17. Kopishinskaya SV, Gustov AV. Genetic aspects of migraine. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 2015;115(7):124-129. (In Russ.). https://doi.org/10.17116/jnevro201511571124-129
  18. Retinal Vasculopathy with Cerebral Leukodystrophy (RVCL). Accessed 10/9/2013. https://www.nimbl.eu/ni/Home. NIMBL. 2013;
  19. Stam AH, Kothari PH, Shaikh A, Gschwendter A, Jen JC, Hodgkinson S, Hardy TA, Hayes M, Kempster PA, Kotschet KE, Bajema IM, van Duinen SG, Maat-Schieman ML, de Jong PT, de Smet MD, de Wolff-Rouendaa lD, Dijkman G, Pelzer N, Kolar GR, Schmidt RE, Lacey J, Joseph D, Fintak DR, Grand MG, Brunt EM, Liapis H, Hajj-Ali RA, Kruit MC, van Buchem MA, Dichgans M, Frants RR, vanden Maagdenberg AM, Haan J, Baloh RW, Atkinson JP, Terwindt GM, Ferrari MD. Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations. Brain. 2016;139(Issue 11):2909-2922. https://doi.org/10.1093/brain/aww217
  20. Politei JM, Bouhassira D, Germain DP, Goizet C, Guerrero-Sola A, Hilz MJ, Hutton EJ, Karaa A, Liguori R, Üçeyler N, Zeltzer LK, Burlina A. Pain in Fabry Disease: Practical Recommendations for Diagnosis and Treatment. CNS Neurosci Ther. 2016;22(7):568-576. Epub 2016 Mar 28.  https://doi.org/10.1111/cns.12542
  21. Duering M, Csanadi E, Gesierich B. Incident lacunes preferentially localized to the edge of white matter hyperintensities: insights into the pathophysiology of cerebral small vessel disease. Brain. 2013;136:2717-2726. https://doi.org/10.1161/01.STR.0000240513.00579.bf
  22. Valdes Hernandez Mdel C, Maconick LC, Munoz Maniega S. A comparison of location of acute symptomatic vs. ‘silent’ small vessel lesions. Int J Stroke. 2015;10:1044-1050. https://doi.org/10.1111/ijs.12558
  23. Schmidt R, Seiler S, Loitfelder M. Longitudinal change of small-vessel disease-related brain abnormalities. J Cereb Blood Flow Metab. 2016;36:26-39.  https://doi.org/10.1038/jcbfm.2015.72
  24. Charidimou A, Pantoni L, Love S. The concept of sporadic cerebral small vessel disease: A road map on key definitions and current concepts. https://doi.org/10.1177/1747493015607485
  25. Vermeer SE, Longstreth WT, Koudstaal PJ. Silent Brain Infarcts: A Systematic Review. The Lancet Neurology. 2007;6:611-619.  https://doi.org/10.1016/S1474-4422(07)70170-9
  26. Putilina MV. Strategies of cerebral small vessel disease early diagnostics and therapy. Consilium Medicum. 2018;20(9):22-29. (In Russ.). https://doi.org/10.26442/2075-1753_2018.9.22-29
  27. Shi Y, Wardlaw JM. Update on cerebral small vessel disease: a dynamic whole-brain disease. https://doi.org/10.1136/svn-2016-000035
  28. Arablinskiy AV, Makotrova TA, Trusova NA, Levin OS. Magnetic resonance imaging markers of cerebral microangiopathy. Russian Electronic Journal of Radiology. 2014;1:24-31. (In Russ.). https://www.rejr.ru
  29. Mishchenko VM, Sokolyk VV. Brain small vessels disease (neuroimaging and biochemical markers). Ukrainskij Vestnik Psihonevrologii. 2014;4(81):41-45. (In Russ.).
  30. Arboix A, Alsina M, Caballero M, Parra O, Massons J, Sánchez M-J. Lacunar Infarcts: Clinical and Risk Factorsin 864 Patients. J Heart Stroke. 2017;2(3):1023.
  31. Jain KK. The Handbook of Biomarkers. NY.: Humana Press; 2010.
  32. Putilina MV. Endothelium as a target for new therapeutic strategies in cerebral vascular diseases. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 2017;117(10):122-130. (In Russ.). https://doi.org/10.17116/jnevro2017117101122-130
  33. Moran C, Phan TG, Srikanths VK. Cerebral small vessel disease: a review of clinical, radiological, and histopathofogical phenotypes. Int J Stroke. 2012;7(1):36-46.  https://doi.org/10.1111/j.1747-4949.2011.00725.x
  34. Wardlaw JM, Smith C, Dichgans M. Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging. The Lancet Neurology. 2013;12(5):483-497.  https://doi.org/10.1016/S1474-4422(13)70060-7
  35. Esin RG, Esin OR, Khairullin IKh. Discirculatory encephalopathy and small vessel disease. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 2016;8:109-115. (InRuss.). https://doi.org/10.17116/jnevro201611681109-113
  36. Cooper SA, Whaley-Connell A, Habibi J. Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance. American Journal of Physiology: Heart and Circulatory Physiology. 2007;293(4):2009-20235. https://doi.org/10.1152/ajpheart.00522.2007
  37. Shanmuganathan R, Kumaresan R, Giri P. Prevalence of angiotensin converting enzyme (ACE) gene insertion/deletion polymorphism in South Indian population with hypertension and chronic kidney disease. Journal of Postgraduate Medicine. 2015;61(4):230-234.  https://doi.org/10.4103/0022-3859.166510
  38. Van Rijn MJE, Bos MJ, Isaacs A. Polymorphisms of the renin-angiotensin system are associated with blood pressure, atherosclerosis and cerebral white matter pathology. Journal of Neurology, Neurosurgery & Psychiatry. 2007;78(10):1083-1087. https://doi.org/10.1136/jnnp.2006.109819
  39. Passaro A, Dalla Nora E, Marcello C, Di Vece F, Morieri ML, Sanz JM. PPARγ, Pro12Ala and ACE ID polymorphisms are associated with BMI and fat distribution, but not metabolic syndrome. Cardiovasc Diabetol. 2011;10:112.  https://doi.org/10.1186/1475-2840-10-112
  40. Schmidt R, Schmidt H, Fazekas F. Angiotensinogen polymorphism M235T, carotid atherosclerosis, and small‐vessel disease‐related cerebral abnormalities. Hypertension. 2001;38:110-115. PMID: 11463770.
  41. Takami S, Imai Y, Katsuya T. Gene polymorphism of the rennin — angiotensin system associates with risk for lacunar infarction. The Ohasama Study. Am J Hypertens. 2000;13(2):121-127.  https://doi.org/10.1016/s0895-7061(99)00184-3
  42. Mondry A, Loh M, Liu P. Polymorphism of the insertion/deletion ACE and M235T AGT genes and hypertension: surprising new finding and meta-analysis of data. BMC Nephrol. 2005;6:1.  https://doi.org/10.1186/1471-2369-6-1
  43. Elshamaa MF, Sabry SM, Bazaraa HM, Koura HM, Elghoroury EA, Kantoush NA. Genetic polymorphism of ACE and the angiotensin II type1 receptor genes in children with chronic kidney disease. J Inflamm (Lond). 2011;8:20.  https://doi.org/10.12659/MSM.892140
  44. Shi Y, Thrippleton MJ, Makin SD. Cerebral blood flow in small vessel disease: a systematic review and meta-analysis. J Cereb Blood Flow Metab. 2016. Published online first: 5 Aug 2016. https://doi.org/10.1177/0271678X16662891
  45. Brenner D, Labreuche J, Pico F. The renin-angiotensin-aldosterone system in cerebral small vessel disease. Journal of Neurology. 2008;255(7):993-1000. https://doi.org/10.1007/s00415-008-0816-8
  46. Connell JMC, Fraser R, MacKenzie S, Davies E. Is altered adrenal steroid biosynthesis a key intermediate phenotype in hypertension? Hypertension. 2003;41(5):993-999.  https://doi.org/10.1161/01.HYP.0000064344.00173.44
  47. Van Rijn MJE, Bos MJ, Isaacs A. Polymorphisms of the renin-angiotensin system are associated with blood pressure, atherosclerosis and cerebral white matter pathology. Journal of Neurology, Neurosurgery & Psychiatry. 2007;78(10):1083-1087. https://doi.org/10.1136/jnnp.2006.109819
  48. Putilina MV. Anxiety-depressive disorders and stroke: possible etiopathogenetic correlations. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 2014;114(6):86-93. (In Russ.).
  49. Merkin AG, Kazhin VA, Komarov AN, Fonarev AV, Priyatel VA, Nikiforov IA. Prevention of cerebrovascular diseases and cognitive impairment in psychiatric and neurological practice: A literature review. Neurology, Neuropsychiatry, Psychosomatics. 2016;8(3):95-100. (In Russ.) https://doi.org/10.14412/2074-2711-2016-3-95-100
  50. Taylor WD, Aizenstein HJ, Alexopoulos GS. The vascular depression hypothesis: mechanisms linking vascular disease with depression. Molecular Psychiatry. 2013;18(9):963-974.  https://doi.org/10.1038/mp.2013.20
  51. Cheng W, Rolls ET, Qiu J, Liu W, Tang Y, Huang CC, Wang X, Zhang J, Lin W, Zheng L, Pu J, Tsai SJ, Yang AC, Lin CP, Wang F, Xie P, Feng J. Medial reward and lateral non-reward orbitofrontal cortex circuits change in opposite directions in depression. Brain. 2016;139:3296-3309. https://doi.org/10.1093/brain/aww255
  52. Damulin IV, Ekusheva EV. Dementia due to cerebral small vessel damage: Current ideas on its pathogenesis and therapy. Nevrologija, Nejropsihiatrija, Psihosomatika. 2014;6(4):94-100. (In Russ.).
  53. Prins ND, Van Dijk EJ, Den Heijer T. Cerebral small-vessel disease and decline in information processing speed, executive function and memory. Brain. 2005;128(9):2034-2041. https://doi.org/10.1093/brain/awh553
  54. Mazzoni M, Ferroni L, Lombardi L. Mini-Mental State Examination (MMSE): sensitivity in an Italian sample of patients with dementia. Ital J Neuro Sci. 1992;13:323.  https://doi.org/10.1007/BF02223097
  55. Poggesi A, Gouw A, van der Flier W. Neurological abnormalities predict disability: the LADIS (Leukoaraiosis And DISability) study. J Neurol. 2014;261:1160. https://doi.org/10.1007/s00415-014-7332-9
  56. Philip BM, Wardlaw JM. Pharmacological treatment and prevention of cerebral small vessel disease: a review of potential interventions. International Journal of Stroke. 2015;10(4):469-478.  https://doi.org/10.1111/ijs.12466
  57. Makin SDJ, Mubki GF, Doubal FN, Shuler K, Staals J, Dennis MS. Small vessel disease and dietary salt intake: cross-sectional study and systematic review. J Stroke Cerebrovasc Dis. 2017;26:3020-3028. https://doi.org/10.1016/j.jstrokecerebrovasdis.2017.08.004
  58. William M. Feinberg award for excellence in clinical stroke: small vessel disease; a big problem, but fixable. Stroke. 2018;49(7):1770-1775. https://doi.org/10.1161/STROKEAHA.118.021184
  59. Ziganshina LE, Abakumova T, Vernay L. Cerebrolysin for acute ischaemic stroke. Cochrane Database of Systematic Reviews. 2017;4:Art.: CD007026. https://doi.org/10.1002/14651858.CD007026.pub5
  60. Rockenstein E, Ubhi K, Trejo M. Cerebrolysin efficacy in a transgenic model of tauopathy: role in regulation of mitochondrial structure. BMC Neuroscience. 2014;90.  https://doi.org/10.1186/1471-2202-15-90
  61. Rockenstein E. Effects of Cerebrolysin on neurogenesis in an APP transgenic model of Alzheimer’s disease. Acta Neuropathol. 2007;113:265-2.  https://doi.org/10.1007/s00401-006-0166-5
  62. Hartbauer M, Hutter-Paie B, Windisch M. Effects of Cerebrolysin on the outgrowth and protection of processes of cultured brain neurons. Journal of Neuraltransmission. 2001;108(5):581-592. 
  63. Zhang Li, Chopp M, Meier DH, Winter S, Wang L, Szalad A, Lu M, Wei M, Cui Y, Zhang ZG. Sonic hedgehog signaling pathway mediates cerebrolysin-improved neurological function after stroke. Stroke. 2013;44:00-00.  https://doi.org/10.1161/strokeaha.111.000831
  64. Alvarez XA, Alvarez I, Iglesias O, Crespo I, Figueroa J, Aleixandre M, Linares C, Granizo E, Garcia-Fantini M, Marey J, Masliah E, Winter S, Muresanu D, Herbert Moessler H. Synergistic Increase of Serum BDNF in Alzheimer Patients Treated with Cerebrolysin and Donepezil: Association with Cognitive Improvement in ApoE4 Cases. Int J Neuropsychopharmacol. 2016;19(6):pyw024. https://doi.org/10.1093/ijnp/pyw024
  65. Guekht AB, Moessler H, Novak PH, Gusev E.I. Cerebrolysin in vascular dementia: improvement of clinical outcome in a randomized, double-blind, placebo-controlled multicenter trial. J Stroke Cerebrovasc Dis. 2011;20(4):310-318.  https://doi.org/10.1016/j.jstrokecerebrovasdis.2010.01.012

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.